This page shows Non Invasive (NIMU) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Non Invasive passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.
For every $1 of reported earnings, Non Invasive generates $0.53 in operating cash flow (-$117K OCF vs -$222K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Non Invasive earns $-2.6 in operating income for every $1 of interest expense (-$160K vs $62K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Non Invasive reported -$222K in net income in fiscal year 2025. This represents a decrease of 96.5% from the prior year.
Non Invasive held $6K in cash against $0 in long-term debt as of fiscal year 2025.
Non Invasive had 155M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Non Invasive's ROE was 22.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 8.4 percentage points from the prior year.
NIMU Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $25K | N/A | $26K0.0% | $26K-58.7% | $63K | N/A | $30K-25.0% | $40K |
| Operating Income | -$25K | N/A | -$26K0.0% | -$26K+58.7% | -$63K | N/A | -$30K+25.0% | -$40K |
| Interest Expense | $17K | N/A | $16K0.0% | $16K+14.3% | $14K | N/A | $14K0.0% | $14K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$42K | N/A | -$42K0.0% | -$42K+45.5% | -$77K | N/A | -$44K+18.5% | -$54K |
| EPS (Diluted) | $0.00 | N/A | $0.00 | $0.00 | $0.00 | N/A | $0.00 | $0.00 |
NIMU Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6K-14.3% | $7K-72.0% | $25K-41.9% | $43K+13.2% | $38K+11.8% | $34K-57.5% | $80K-20.8% | $101K |
| Current Assets | $6K-14.3% | $7K-72.0% | $25K-41.9% | $43K+13.2% | $38K+11.8% | $34K-57.5% | $80K-20.8% | $101K |
| Cash & Equivalents | $6K+100.0% | $3K-81.3% | $16K-40.7% | $27K+80.0% | $15K-40.0% | $25K-60.9% | $64K-14.7% | $75K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $995K+4.3% | $954K+4.7% | $911K+2.7% | $887K+5.6% | $840K+10.7% | $759K-13.6% | $878K+2.7% | $855K |
| Current Liabilities | $995K+4.3% | $954K+4.7% | $911K+2.7% | $887K+5.6% | $840K+421.7% | $161K-45.1% | $293K+3.2% | $284K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$989K-4.4% | -$947K-6.9% | -$886K-5.0% | -$844K-5.2% | -$802K-10.6% | -$725K+9.1% | -$798K-5.8% | -$754K |
| Retained Earnings | -$29.1M-0.1% | -$29.1M-0.2% | -$29.0M-0.1% | -$29.0M-0.1% | -$28.9M-0.3% | -$28.8M+0.3% | -$28.9M-0.2% | -$28.9M |
NIMU Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$22K-69.2% | -$13K-18.2% | -$11K+60.7% | -$28K+56.9% | -$65K-66.7% | -$39K-254.5% | -$11K+84.5% | -$71K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $25K | $0 | $0-100.0% | $40K-27.3% | $55K | $0 | $0 | $0 |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NIMU Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | 4.2% | N/A | 4.7%-0.2pp | 5.0%-4.6pp | 9.6% | N/A | 5.5%-1.6pp | 7.2% |
| Return on Assets | -700.0% | N/A | -168.0%-70.3pp | -97.7%+105.0pp | -202.6% | N/A | -55.0%-1.5pp | -53.5% |
| Current Ratio | 0.010.0 | 0.01-0.0 | 0.03-0.0 | 0.050.0 | 0.05-0.2 | 0.21-0.1 | 0.27-0.1 | 0.36 |
| Debt-to-Equity | -1.010.0 | -1.01+0.0 | -1.03+0.0 | -1.050.0 | -1.050.0 | -1.05+0.1 | -1.10+0.0 | -1.13 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$989K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
Is Non Invasive profitable?
No, Non Invasive (NIMU) reported a net income of -$222K in fiscal year 2025.
What is Non Invasive's earnings per share (EPS)?
Non Invasive (NIMU) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Non Invasive's return on equity (ROE)?
Non Invasive (NIMU) has a return on equity of 22.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Non Invasive's operating cash flow?
Non Invasive (NIMU) generated -$117K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Non Invasive's total assets?
Non Invasive (NIMU) had $6K in total assets as of fiscal year 2025, including both current and long-term assets.
How many shares does Non Invasive have outstanding?
Non Invasive (NIMU) had 155M shares outstanding as of fiscal year 2025.
What is Non Invasive's current ratio?
Non Invasive (NIMU) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Non Invasive's debt-to-equity ratio?
Non Invasive (NIMU) had a debt-to-equity ratio of -1.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Non Invasive's return on assets (ROA)?
Non Invasive (NIMU) had a return on assets of -3700.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Non Invasive's cash runway?
Based on fiscal year 2025 data, Non Invasive (NIMU) had $6K in cash against an annual operating cash burn of $117K. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Non Invasive's debt-to-equity ratio negative or unusual?
Non Invasive (NIMU) has negative shareholder equity of -$989K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Non Invasive's Piotroski F-Score?
Non Invasive (NIMU) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Non Invasive's earnings high quality?
Non Invasive (NIMU) has an earnings quality ratio of 0.53x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Non Invasive cover its interest payments?
Non Invasive (NIMU) has an interest coverage ratio of -2.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.